Banned pharmaceutical drugs discovered in the US drug

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
121
Banned pharmaceutical drugs discovered in the US drug supply, USDA decides to do nothing

https://www.naturalhealth365.com/banned-pharm...-2699.html

A new article in Consumer Reports has blown the lid off an ongoing food safety scandal – and revealed that traces of banned and restricted pharmaceutical drugs have been found in beef, poultry and pork headed for supermarkets and supper tables throughout the United States.

The drug residues include ketamine – a veterinary anesthetic with hallucinogenic effects – phenylbutazone – an anti-inflammatory medication considered too risky to human health to use – and chloramphenicol, a potent antibiotic associated with a life-threatening form of anemia.

Meanwhile, U.S. federal agencies meant to ensure food safety appear to be turning a blind eye.

Consumer Reports scientists analyzed data from tests performed on thousands of meat samples
To obtain their findings, the scientists examined United States Department of Agriculture (USDA) tests that had been performed on nearly 6,000 random samples of beef, poultry and pork.

The team also examined government documents and conducted interviews with government officials, doctors, industry groups and farmers.

The test results and documents were obtained through the Freedom of Information Act as part of a lawsuit brought by food safety organizations against Sanderson Farms, the third largest poultry producer in the nation. The lawsuit alleges that the company’s claims of producing “natural” and “antibiotic-free” poultry are misleading.

All of the scientists were employed by Consumers Union – the publisher of Consumer Reports magazine. And, Consumers Union is an independent, non-profit organization dedicated to unbiased research and consumer protection.

Bombshell findings on potentially dangerous pharmaceutical drugs met with shrugs from the USDA
Shockingly, 2.6 percent of the samples of poultry, beef and pork contained chloramphenicol in amounts that exceeded the cutoff levels established by Consumer Report’s team of scientists.

Chloramphenicol at any level can cause life-threatening aplastic anemia – the inability to produce sufficient new blood cells – in 1 out of 10,000 people.

In addition, 1.6 percent of the samples contained phenylbutazone, a drug no longer used in humans because of its “double whammy” of potential health hazards. Not only is phenylbutazone associated with aplastic anemia as well, but it is a possible carcinogen.

Traces of ketamine, an anesthetic with hallucinogenic properties, were also found. Sometimes abused as a “party drug,” ketamine is currently restricted by the government.

To be clear: all three drugs are prohibited from use in animals meant for human consumption. But, no one is certain how these prohibited drugs are even ending up in the meat supply.

Some industry experts theorize that contamination could occur through runoff from excrement into soil and water – which then enters drinking water and feed given to livestock.

Intentional or accidental misuse – in which producers use the drugs to accelerate growth – could also be a factor, as could mislabeled or counterfeit drugs.

While the concentration of drug residue liable to cause harm in humans is ‘unknown,’ recent studies indicate that long-term exposure to even low levels could raise the risk of cancer, antibiotic resistance, and harm to developing fetuses.

To date, the response of the USDA’s Food Safety and Inspection Service (or FSIS) has been non-existent.

USDA denies the validity of its own data
Emilio Esteban, Ph.D., chief scientist at FSIS, claims the Consumer Reports’ team’s findings are the result of “unconfirmed” screening tests – and says they should be discounted.

By the way, the scientists used the USDA’s own data to reach their conclusions!

In many cases, Dr. Esteban said, the results were below levels considered to be of concern by FSIS – and didn’t meet agency criteria that would necessitate follow-up testing.

The cut-off levels – also known as minimum levels of applicability – set by the FSIS are significantly higher than those utilized by the Consumer Reports team – and much higher than those used by other government agencies. In fact, many natural health advocates and food safety experts – including Consumers Union – have urged FSIS to use more widely accepted scientific standards.

Scholars, scientists and natural health advocates call for action
Consumer Reports’ Director of Food and Safety Research and Testing, James E. Rogers, PhD, expressed his disappointment at the lack of response from FSIS.

“You would hope the results would prompt the agency to look into why these drugs may be present, what risks they could pose, and what could be done to protect consumers,” commented Dr. Rogers.

Charles Benbrook, Ph.D., a scholar with the Bloomberg School of Public Health at Johns Hopkins University, agrees.

Dr. Benbrook noted that the findings should have resulted in “aggressive” action to figure out how the drugs are ending up in meat.

And Andrew Gunther – executive director of A Greener World, a non-profit organization that promotes sustainable farming – called the drugs “potentially very dangerous.” He professed to be “floored” by the alarming results, saying that the contaminants appeared in more samples, and at higher levels, than he would have expected.

FSIS has taken little action, as agency officials downplay results
The responsibility for enforcing food safety regulations and assigning penalties lies with the Food and Drug Administration (FDA).

But Consumer Reports points out that the agency has issued very few citations, to date, for drugs that shouldn’t be in meat in the first place. (Meat producers are more likely to be cited for exceeding residue limits for approved drugs).

And FDA penalties – such as warning letters, injunctions, and the placing of repeat violators on a public list – amount to little more than a “slap on the wrist.”

Lest there be any doubt regarding the ineffectuality of the current penalties, Parthapratim Basu, D.V.M. – former Chief Public Health Veterinarian at FSIS – offers up an infuriating example.

Do you think meat producers really care about FDA warning letters?
According to Dr. Basu, many meat producers seem to view a warning letter from the FDA with a distinct lack of alarm. Some even consider it a point of pride – and utilize the letters to “cover holes in the barn.”

Not only has FSIS failed to ensure that meat intended for human consumption is free of drugs, but the agency continues to downplay and minimize the actual presence of these contaminants.

A FSIS spokesperson quoted by Consumer Reports characterizes the data as “preliminary,” “unconfirmed” and “misleading,” and announced that it did not represent any public health risk to consumers.

And, an official at the National Chicken Council says conclusions based on preliminary results “would amount to fearmongering and needless alarm.”

There you have it: the discovery of the true amounts of potentially dangerous drug residues in the American meat supply is being met with stalling, hesitation and outright denial. In light of this (I’m sure you would agree), the decision to choose meat from organic farms – which are required by federal law to raise their livestock without drugs or other chemicals – should be a no-brainer.

Sources for this article include:
Consumer Reports
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Austin PostalAnnex Changes Hands After 19 Years

Updated Category News Views 3

A Seamless Transition in Austin's PostalAnnex Legacy You know when a business digs its roots deep, becoming more than just a place but a part of the community fabric? That's what’s playing out at the PostalAnnex on W Parmer Lane, Austin. After nearly two decades, this battered yet steadfast hub of office and shipping services is swapping hands, all in the name of...

Continue Reading
Alif Semiconductor Unveils StartKit for Edge AI MCU Fam

Updated Category News Views 1

Here's some clarity amidst the storm of buzzwords: Alif Semiconductor has rolled out something the market's been howling for—Edge AI that doesn't break the bank. It's less about slick press releases and more about real-world implications. We're talking accessibility with their dirt-cheap, small-form-factor StartKit platform for Ensemble and Balletto microcontrollers....

Continue Reading
ASCEND® Cladding Unveils New Profiles & Texture Variety

Updated Category News Views 1

New Options for Creative Home Exteriors Amid today's housing market rollercoaster, a sprinkle of bold innovation in building materials can make a statement—and that's precisely what Associated Materials Innovations (AMI) is banking on with their latest beef-up in the ASCEND® Composite Cladding lineup. Introduced out of Cuyahoga Falls on Sept. 8, 2026, this expansion...

Continue Reading
Celebree Elevates Early Ed with New Certification Push

Updated Category News Views 3

A New Standard in Early Childhood Education In the cutthroat world of childcare and early education, just meeting the state standards ain't cutting it anymore. Celebree School, known for its infant, toddler, and preschool programs, is shaking things up with its 'Celebree Certified' initiative, setting a brand-new benchmark for teacher readiness that's far beyond the usual...

Continue Reading
Goodwill's ReThink Fashion: Textiles to Runway Art

Updated Category News Views 2

Transforming Old to New on the Runway Right when you think fashion's all about the next shiny thing, here comes Goodwill of Delaware & Delaware County flipping the script. Their ReThink Fashion Show - the ECO Edit teaches us a thing or two about what giving old clothes a new life truly means. It's not just about tossing a used tee onto a catwalk but a whole rebirth...

Continue Reading
Tiger Group to Auction Huge Window Manufacturing Plant

Updated Category News Views 3

Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...

Continue Reading
The Austin Company to Showcase at ISPE Annual Event

Updated Category News Views 1

Setting the Stage at ISPE Expo When you think of pharmaceuticals and the bustle behind closed doors, it's with companies like The Austin Company leading the charge. This October, they're strutting their stuff at the ISPE Annual Meeting and Expo. No small potatoes here—it's at the Gaylord National in Maryland. Mark those dates: October 18-21, 2026. It's a circus of...

Continue Reading
Hanover Unveils Skinny Veg® for GLP-1 Dieters

Updated Category News Views 1

Seems like Hanover Foods is turning heads with their move into the ever-demanding health-conscious market. This family's stepping into the limelight with their new Skinny Veg® line, clearly targeting folks riding the GLP-1 wave. You see, it's not every day that a company that's been around the block since 1924 shakes things up like this. Simplicity is the Name of the...

Continue Reading
Big Wins at Americas Cardroom's $15M Venom Series

Updated Category News Views 2

High Stakes and Huge Paydays: The Venom Breakdown Alright, folks, here's a tale of how the cards fell in one of the most electrifying poker standoffs at Americas Cardroom. With prize pools clocking in at a staggering $15.095 million, the Dual Mystery Bounty Venoms really stacked the chips high. From the gritty, bustling halls of the internet to the proverbial green-felt...

Continue Reading
Intellectia.AI Transforming Trading with AI Upgrades

Updated Category News Views 1

Intellectia.AI Sparks New Trading Era Intellectia.AI, from the bustling streets of New York, is cutting through the noise with a flashy update to its AI-powered trading setup. They've thrown a heap of new toys into the ring, letting folks piggyback on high-grade stock moves in the blink of an eye. Gone are the days of fumbling with cumbersome data and execution. Breaking...

Continue Reading

Top 5 Most Recently Viewed Articles

Starbucks' New CEO Aims to Revitalize the Coffee Giant

Updated Category News Views 116

Starbucks Welcomes a New CEO Starbucks, the iconic coffee brand, has recently appointed Brian Niccol as its new CEO. This pivotal move could change the company's trajectory for the future. Niccol, who previously led Chipotle Mexican Grill, comes on board with a compensation package exceeding $110 million, reflecting the high expectations the Starbucks team has for him....

Continue Reading
Summit Global Investments Achieves Recognition from Newsweek

Updated Category News Views 122

Summit Global Investments Acknowledged as Top Financial Advisors Summit Global Investments has been proudly distinguished as one of America's Top Financial Advisory Firms for the upcoming year. This recognition by Newsweek and Plant-A Insights Group stems from a comprehensive study analyzing over 15,000 financial advisory firms registered with the SEC. Understanding the...

Continue Reading
Prosperity Bancshares and American Bank Announce Exciting Merger

Updated Category News Views 234

Prosperity Bancshares Announces Strategic Merger with American Bank Prosperity Bancshares, Inc. (NYSE: PB) has made a significant move in the financial sector by announcing its merger with American Bank Holding Corporation. This merger is an exciting opportunity that aims to enhance shareholder value while expanding the range of services offered by both entities. Such...

Continue Reading
Fortress Biotech Celebrates Major Financing for Dotinurad

Updated Category News Views 135

$205 Million Series A Financing for Crystalys Therapeutics Urica Therapeutics, a subsidiary of Fortress Biotech, Inc. (NASDAQ: FBIO), has recently announced a remarkable achievement with Crystalys Therapeutics closing a $205 million Series A financing round. This enticing funding aims to propel global Phase 3 clinical studies for dotinurad, a revolutionary treatment for...

Continue Reading
Scott Aaronson Steps In as Pike's New CCO

Updated Category News Views 17

Electric grid development isn't kid stuff, folks, and Pike Corporation just took a bold step in that direction, roping in Scott Aaronson as the new Chief Commercial Officer. Aaronson’s not just any utility sector suit; he's got 17 years of experience under his belt from Edison Electric Institute (EEI) where his influence was as imposing as high transmission lines. Scott...

Continue Reading